Skip to content

Bioventus BVS Debt Repayments

Debt Repayments at other companies

Stryker logo
StrykerSYK
$1B
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$127.5M+546%
Medtronic logo
MedtronicMDT
$1.77B
Globus Medical logo
Globus MedicalGMED
$0-100%
Artivion logo
ArtivionAORT
$0-100%
Enovis logo
EnovisENOV
$35.52M+240%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's debt repayments?
Bioventus (BVS) reported debt repayments of $0 in Q1 2026.
How has Bioventus's debt repayments changed year-over-year?
Bioventus's debt repayments decreased by 100.0% year-over-year, from $5M to $0.
What is the long-term trend for Bioventus's debt repayments?
Over 4 years (2021 to 2025), Bioventus's debt repayments has grown at a 22.5% compound annual growth rate (CAGR), from $20M to $45M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.